Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-?B pathway
10.1038/s41598-018-28213-3
Saved in:
Main Authors: | Sim M.Y., Yuen J.S.P., Go M.L. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
Nature Publishing Group
2019
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/152527 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
INVESTIGATIONS OF YM155, AN INHIBITOR OF SURVIVIN, AS A MOLECULAR MULTI-TARGETED AGENT FOR RENAL CELL CARCINOMA
by: SIM MEI YI
Published: (2016) -
The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma
by: Xia H., et al.
Published: (2020) -
Action of YM155 on clear cell renal cell carcinoma does not depend on surviving expression levels
by: Sim M.Y., et al.
Published: (2019) -
GROWTH INHIBITORY DIXONAPHTHOIMIDAZOLIUMS RELATED TO YM155: SYNTHESIS AND MECHANISTIC INVESTIGATIONS
by: HO SI HAN, SHERMAN
Published: (2015) -
Expression of the inhibitor of apoptosis protein survivin in benign meningiomas
by: Asha Das, et al.
Published: (2018)